Document is current
Any future updates will be listed below
-
Authors
Liu, Guobing
Gu, Yushen
Sollini, Martina
Lazar, Alexandra
Besson, Florent L.
Li, Sijin
Wu, Zhifang
Nardo, Lorenzo
Al-Ibraheem, Akram
Zheng, Jiefu
Kulkarni, Harshad R.
Rominger, Axel
Fan, Wei
Zhu, Xiaohua
Zhao, Xinming
Wu, Hubing
Liu, Jianjun
Li, Biao
Cheng, Zhaoping
Wang, Ruimin
Xu, Baixuan
Agostini, Denis
Tang, Han
Tan, Lijie
Yang, Zhi
Huo, Li
Gu, Jianying
Shi, Hongcheng https://orcid.org/0000-0001-7457-876X
-
Funding
Funding for this research was provided by:
the Innovative Medical Device Application Demonstration Program of Shanghai Municipal Commission of Economy and Informatization (23SHS01200)
the Chinese National Key Clinical Specialty Program (YWP2022-007)
the National Key Research and Development Program of China (2022YFC2406902)
- License Information
-
More Information
Article History
Received: 15 July 2024
Accepted: 26 October 2024
First Online: 9 November 2024
Declarations
:
: Zhongshan Hospital affiliated to Fudan University has a strategic partnership with United Imaging Healthcare (UIH) and professor Hongcheng Shi has been commonly invited to offer a lecture to UIH. UC Davis has a research agreement and a sales-based revenue-sharing agreement with United Imaging Healthcare. UIH partially supports a fellowship training program at UC Davis. Harshad Kulkarni from BAMF Health is part of the Speaker bureau of United Imaging within the past 2 years. Some investigator-initiated research projects at BAMF Health were funded by United Imaging. Axel Rominger receives speaker honoraria from Siemens and has research agreement ongoing. Martina Sollini is a member of the EJNMMI Editorial Board and an Associate Editor for the “Artificial intelligence, machine learning and radiomics” section of Cancer Imaging. Other authors declare no conflict of interest regarding this article.
: Institutional Review Board approval was not required because this is a expert consensus.
: Not applicable.
: Not applicable.
